Yervoy/Opdivo (nivolumab/ipilimumab)

pCPA File Number: 21083
Negotiation Status:
Concluded with an LOI
Indication(s):
renal cell carcinoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10132
pCPA Engagement Letter Issued:
Negotiation Process Concluded: